New guidelines for the management of valvular heart disease introduce over 45 revised or new recommendations to the previous version published in 2017, revealed members of the writing committee presenting the updated guidelines during the annual congress of the European Society of Cardiology.

The guidelines emphasize on early diagnosis and expansion of indications, the significance of clinical examination as well as the best strategies for diagnosis and treatment. The highest number of revisions and new additions involve perioperative antithrombotic therapy. A total of 11 new recommendations on the use of anticoagulants or antiplatelet treatment have been included. The next major focus of the guidelines involves when to consider surgical aortic valve repair (SAVR) relative to transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis… (Medscape)